These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection. Kountz SL, Rao TK, Butt KH. Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048 [No Abstract] [Full Text] [Related]
3. Chronic rejection of renal allografts with four immunosuppressive regimens. Isoniemi H, Ahonen J, Krogerus L, Eklund B, Höckerstedt K, Salmela K, Häyry P. Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912 [No Abstract] [Full Text] [Related]
4. Can a diagnosis of renal allograft rejection be based on histology alone? Midtvedt K, Hartmann A, Sund S. Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323 [Abstract] [Full Text] [Related]
5. Chagas disease and transplantation. Vazquez MC, Sabbatiello R, Schiavelli R, Maiolo E, Jacob N, Pattin M, Rearte A. Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281 [No Abstract] [Full Text] [Related]
6. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis. Moreno RF, Pallardo LM, Garcia J, Sanchez J, Rochera A, Cabezuelo J, de Agustin PP. Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590 [No Abstract] [Full Text] [Related]
7. Posttransplant serum creatinine area under the curve predicts renal allograft outcome. Sumrani N, Hong J, Miles A, Markell M, Distant D, Fleishhacker J, Maursky V, Jean-Baptiste F, Sommer B. Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260 [No Abstract] [Full Text] [Related]
8. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK. Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743 [Abstract] [Full Text] [Related]
9. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR. Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [Abstract] [Full Text] [Related]
13. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months. Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R. Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521 [Abstract] [Full Text] [Related]
14. The role of clinical transplantation in patients with end-stage renal disease. Belzer FO, Kountz SL. Transplant Proc; 1973 Mar; 5(1):793-7. PubMed ID: 4121182 [No Abstract] [Full Text] [Related]
15. Donor pretreatment as an adjunct to cadaver renal allotransplantation. Guttman RD, Beaudoin JG, Morehouse DD, Klassen J, Knaack J, Jeffery J, Chassot PG, Abbou CC. Transplant Proc; 1975 Mar; 7(1):117-21. PubMed ID: 123373 [No Abstract] [Full Text] [Related]